Tocriscreen FDA-Approved Drugs Library

Biological Activity

Tocriscreen FDA-Approved Drugs Library is a library of 190 compounds equivalent to the pharmacologically active components of drug formulations approved by the FDA. Compounds supplied pre-dissolved in DMSO (100 μL, 10 mM solution). Contains compounds covering a diverse range of pharmaceutical targets and therapeutic areas e.g. immunology, oncology. Includes both established therapeutics, e.g. tamoxifen (Cat. No. 0999) and paclitaxel (Cat. No. 1097), as well as more recently approved drugs such as darunavir (Cat. No. 6710) and sorafenib (Cat. No. 6814). Ideal for in vitro and in vivo drug repurposing/repositioning studies.

This library replaces the Tocriscreen Library of FDA-Approved Compounds (Cat. No. 5932).

All Tocris products are for biomedical research use only. They are not intended for human or veterinary use.

Key Format and Product Details

The Tocriscreen FDA-approved Drugs Library contains bioactive compounds covering a diverse range of therapeutic classifications, derived using the WHO Anatomical Therapeutic Chemical Classification System code (ATC code).

Request Compound List

A list of the compounds available in the Tocriscreen FDA-Approved Drugs Library can be requested in Excel or SD format via our Tocriscreen & Custom Library Inquiries form.

Technical Data

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Additional Information

Background References

1. The University of New Mexico Center for Molecular Discovery.
   Edwards et al.
   Comb.Chem.High Throughput Screen., 2014;17:256
2. Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons.
   Li et al.
   Cell Stem Cell, 2015;17:195

Product Datasheets